Literature DB >> 23944863

Clinical survey on contrast-induced nephropathy after coronary angiography.

Feng Wang1, Junhui Li, Baorui Huang, Qing Zhao, Gang Yu, Changyou Xuan, Meng Wei, Niansong Wang.   

Abstract

OBJECTIVE: To investigate the incidence and risk factors of contrast-induced nephropathy (CIN) in patients receiving coronary angiography (CAG) in a Chinese medical center.
METHODS: The medical records of the patients receiving CAG at Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University from January 2008 to July 2009 were collected to analyze the incidence of CIN under different conditions and the clinical difference between CIN group and non-CIN group.
RESULTS: There were 487 cases enrolled in this study and the total incidence of CIN was 10.5%. Through Mehran risk score stratification, incidence of CIN increased with risk scores and in an extremely high-risk group it was as high as 18.0%. Multi-factor regression analysis showed that preoperative hypotension, heart failure, anemia and low estimated glomerular filtration rate (≤30 mL/min) were risk factors of CIN after CAG.
CONCLUSION: CIN post CAG is associated with preoperative hypotension, heart failure, anemia and renal function. Close attention should be paid to CIN in patients receiving CAG.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944863     DOI: 10.3109/0886022X.2013.823874

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats.

Authors:  Binghui Zhao; Qing Zhao; Junhui Li; Tao Xing; Feng Wang; Niansong Wang
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

2.  Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis.

Authors:  Feng Wang; Guangyuan Zhang; Yang Zhou; Dingkun Gui; Junhui Li; Tao Xing; Niansong Wang
Journal:  Oxid Med Cell Longev       Date:  2014-10-21       Impact factor: 6.543

3.  Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase.

Authors:  Feng Wang; Jianyong Yin; Zeyuan Lu; Guangyuan Zhang; Junhui Li; Tao Xing; Shougang Zhuang; Niansong Wang
Journal:  EBioMedicine       Date:  2016-05-18       Impact factor: 8.143

Review 4.  The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.

Authors:  Ziliang Ye; Haili Lu; Wenqin Guo; Weiran Dai; Hongqing Li; Huafeng Yang; Lang Li
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  Coronary Atherosclerosis Imaging.

Authors:  Michael Y Henein; Sergio Vancheri; Gani Bajraktari; Federico Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-01-24

6.  Ameliorative effect of melatonin against contrast media induced renal tubular cell injury.

Authors:  Hamid Nasri; Maryam Tavakoli; Ali Ahmadi; Azar Baradaran; Mehdi Nematbakhsh; Mahmoud Rafieian-Kopaei
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.